Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Common Equity (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Common Equity for 9 consecutive years, with $1.8 billion as the latest value for Q1 2026.

  • For Q1 2026, Common Equity fell 13.79% year-over-year to $1.8 billion; the TTM value through Mar 2026 reached $1.8 billion, down 13.79%, while the annual FY2025 figure was $2.0 billion, 1.51% up from the prior year.
  • Common Equity hit $1.8 billion in Q1 2026 for Select Medical Holdings, down from $2.0 billion in the prior quarter.
  • Across five years, Common Equity topped out at $2.3 billion in Q3 2024 and bottomed at $1.3 billion in Q2 2022.
  • Average Common Equity over 5 years is $1.7 billion, with a median of $1.6 billion recorded in 2024.
  • Year-over-year, Common Equity skyrocketed 49.01% in 2024 and then decreased 13.79% in 2026.
  • Select Medical Holdings' Common Equity stood at $1.4 billion in 2022, then increased by 14.09% to $1.5 billion in 2023, then rose by 28.38% to $2.0 billion in 2024, then increased by 1.51% to $2.0 billion in 2025, then dropped by 12.94% to $1.8 billion in 2026.
  • According to Business Quant data, Common Equity over the past three periods came in at $1.8 billion, $2.0 billion, and $2.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.